ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates

L. Thalji1, N. Thalji2, S. Ibrahim3, J. Heimbach2, P. Kamath4, D. Haile1, D. Kor1

1Anesthesiology, Mayo Clinic, Rochester, MN, 2Surgery, Mayo Clinic, Rochester, MN, 3Pediatric Gastroenterology, Mayo Clinic, Rochester, MN, 4Gastroenterology, Mayo Clinic, Rochester, MN

Meeting: 2020 American Transplant Congress

Abstract number: D-141

Keywords: Allocation, Liver transplantation, Outcome, Pediatric

Session Information

Session Name: Poster Session D: Liver: Pediatrics

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Pre-transplant hypernatremia has been shown to predict post-transplant mortality in adult liver transplant (LT) recipients. The effects of hypernatremia in children, however, remain unexplored. We sought to delineate the impact of hypernatremia on both waitlist, and post-transplant outcomes in pediatric LT patients.

*Methods: We studied all pediatric patients (<12-years) listed for isolated LT in the United States between February 2002 - June 2018. The relationship between serum sodium and both 90-day waitlist death/deterioration, and 90-day post-transplant survival were analyzed using Kaplan Meier methods and Cox proportional-hazards models.

*Results: Serum sodium at wait-listing was available for 5,435/6,522 (83%) patients. Hypernatremia (>145mEq/L) was found in 121 (2.2%), versus 4,352 (80.1%) with normonatremia (135-145mmol/L). Compared with normonatremia, hypernatremic patients were sicker, as demonstrated by higher listing Pediatric End-Stage Liver Disease (PELD) scores (median 17 [IQR 8-25] vs 8 [-3-20], p<0.001), and lower glomerular filtration rates (eGFR) (median [IQR] 89ml/min/1.73cm2 [53-124] vs 129ml/min/1.73cm2 [99 – 160], p<0.001). Estimates of 90-day waitlist survival free of death/deterioration were significantly inferior in hypernatremic patients (Figure 1). When accounting for the confounding effects of PELD and renal function, hypernatremia independently predicted a 3-fold increase in the risk of 90-day waitlist death/deterioration (HR 3.12, 95%CI 2.07-4.71; p<0.001). In patients with hypernatremia at time of transplant, unadjusted estimates of 90-day post-transplant survival were 93.4%, versus 96.8% in normonatremic patients (p=0.005). After adjusting for PELD, renal function, cold ischemia time and whole vs. split-graft type, hypernatremia did not confer an added risk of 90-day post-transplant mortality (HR 1.51, 95%CI 0.88-2.57; p=0.135).

*Conclusions: Hypernatremia is rare in pediatric LT candidates, but is frequently associated with more severe disease. While hypernatremia independently predicts inferior 90-day waitlist outcomes, patients that successfully proceed to transplantation do not appear to be disadvantaged with regards to post-transplant survival. As such, consideration should be given for the inclusion of serum sodium in risk stratification models for pediatric liver transplant allocation.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Thalji L, Thalji N, Ibrahim S, Heimbach J, Kamath P, Haile D, Kor D. Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/hypernatremia-predicts-waitlist-death-and-deterioration-but-not-post-transplant-outcomes-in-pediatric-liver-transplant-candidates/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences